CXAPP INC (CXAI) Fundamental Analysis & Valuation

NASDAQ:CXAI • US23248B1098

Current stock price

0.1641 USD
+0 (+1.3%)
At close:
0.162 USD
0 (-1.28%)
After Hours:

This CXAI fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. CXAI Profitability Analysis

1.1 Basic Checks

  • In the past year CXAI has reported negative net income.
  • In the past year CXAI has reported a negative cash flow from operations.
  • In multiple years CXAI reported negative net income over the last 5 years.
  • In the past 5 years CXAI always reported negative operating cash flow.
CXAI Yearly Net Income VS EBIT VS OCF VS FCFCXAI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 2025 0 -20M -40M

1.2 Ratios

  • CXAI's Return On Assets of -41.54% is on the low side compared to the rest of the industry. CXAI is outperformed by 81.62% of its industry peers.
  • With a Return On Equity value of -96.36%, CXAI is not doing good in the industry: 77.94% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -41.54%
ROE -96.36%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
CXAI Yearly ROA, ROE, ROICCXAI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 2025 0 1K 2K 3K 4K

1.3 Margins

  • With an excellent Gross Margin value of 87.39%, CXAI belongs to the best of the industry, outperforming 94.49% of the companies in the same industry.
  • The Profit Margin and Operating Margin are not available for CXAI so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 87.39%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
CXAI Yearly Profit, Operating, Gross MarginsCXAI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 2025 0 -200 -400 -600

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. CXAI Health Analysis

2.1 Basic Checks

  • CXAI does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • CXAI has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
CXAI Yearly Shares OutstandingCXAI Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 5M 10M 15M
CXAI Yearly Total Debt VS Total AssetsCXAI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

2.2 Solvency

  • Based on the Altman-Z score of -4.78, we must say that CXAI is in the distress zone and has some risk of bankruptcy.
  • CXAI has a Altman-Z score of -4.78. This is amonst the worse of the industry: CXAI underperforms 83.46% of its industry peers.
  • CXAI has a Debt/Equity ratio of 0.91. This is a neutral value indicating CXAI is somewhat dependend on debt financing.
  • Looking at the Debt to Equity ratio, with a value of 0.91, CXAI is doing worse than 72.43% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.91
Debt/FCF N/A
Altman-Z -4.78
ROIC/WACCN/A
WACC10.28%
CXAI Yearly LT Debt VS Equity VS FCFCXAI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 2025 0 50M 100M 150M 200M 250M

2.3 Liquidity

  • CXAI has a Current Ratio of 2.23. This indicates that CXAI is financially healthy and has no problem in meeting its short term obligations.
  • The Current ratio of CXAI (2.23) is better than 63.24% of its industry peers.
  • A Quick Ratio of 2.23 indicates that CXAI has no problem at all paying its short term obligations.
  • The Quick ratio of CXAI (2.23) is better than 63.97% of its industry peers.
Industry RankSector Rank
Current Ratio 2.23
Quick Ratio 2.23
CXAI Yearly Current Assets VS Current LiabilitesCXAI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. CXAI Growth Analysis

3.1 Past

  • CXAI shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 54.70%, which is quite impressive.
  • The Revenue for CXAI has decreased by -35.83% in the past year. This is quite bad
EPS 1Y (TTM)54.7%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%9.09%
Revenue 1Y (TTM)-35.83%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-38.47%

3.2 Future

  • CXAI is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 10.64% yearly.
  • CXAI is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 66.31% yearly.
EPS Next Y-20.69%
EPS Next 2Y10.64%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year27.66%
Revenue Next 2Y66.31%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

CXAI Yearly Revenue VS EstimatesCXAI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2023 2024 2025 2026 2027 2M 4M 6M 8M 10M
CXAI Yearly EPS VS EstimatesCXAI Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 2025 2026 2027 -0.2 -0.4 -0.6 -0.8 -1

More info and screens

Find the best growth stocksShow best growing peers

0

4. CXAI Valuation Analysis

4.1 Price/Earnings Ratio

  • CXAI reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Also next year CXAI is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CXAI Price Earnings VS Forward Price EarningsCXAI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CXAI Per share dataCXAI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 -0.2 -0.4 -0.6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y10.64%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. CXAI Dividend Analysis

5.1 Amount

  • CXAI does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

CXAI Fundamentals: All Metrics, Ratios and Statistics

CXAPP INC

NASDAQ:CXAI (4/24/2026, 8:00:01 PM)

After market: 0.162 0 (-1.28%)

0.1641

+0 (+1.3%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)03-30
Earnings (Next)05-18
Inst Owners8.52%
Inst Owner Change0.69%
Ins Owners9.13%
Ins Owner Change0%
Market Cap9.37M
Revenue(TTM)4.58M
Net Income(TTM)-13.47M
Analysts82.86
Price Target1.02 (521.57%)
Short Float %8.32%
Short Ratio0.23
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)19.43%
Min EPS beat(2)-3.2%
Max EPS beat(2)42.07%
EPS beat(4)3
Avg EPS beat(4)32.87%
Min EPS beat(4)-3.2%
Max EPS beat(4)67.32%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-12.45%
Min Revenue beat(2)-15.99%
Max Revenue beat(2)-8.91%
Revenue beat(4)0
Avg Revenue beat(4)-13.6%
Min Revenue beat(4)-29.41%
Max Revenue beat(4)-0.08%
Revenue beat(8)1
Avg Revenue beat(8)-12%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-50%
PT rev (3m)-50%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-25%
Revenue NY rev (3m)-25%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 2.05
P/FCF N/A
P/OCF N/A
P/B 0.67
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.57
EYN/A
EPS(NY)-0.71
Fwd EYN/A
FCF(TTM)-0.18
FCFYN/A
OCF(TTM)-0.18
OCFYN/A
SpS0.08
BVpS0.24
TBVpS-0.09
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -41.54%
ROE -96.36%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 87.39%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.14
Health
Industry RankSector Rank
Debt/Equity 0.91
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 0.83%
Cap/Sales 0.5%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.23
Quick Ratio 2.23
Altman-Z -4.78
F-Score4
WACC10.28%
ROIC/WACCN/A
Cap/Depr(3y)1.76%
Cap/Depr(5y)N/A
Cap/Sales(3y)0.81%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)54.7%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%9.09%
EPS Next Y-20.69%
EPS Next 2Y10.64%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-35.83%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-38.47%
Revenue Next Year27.66%
Revenue Next 2Y66.31%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-12.31%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year50.31%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-41.45%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-41.72%
OCF growth 3YN/A
OCF growth 5YN/A

CXAPP INC / CXAI Fundamental Analysis FAQ

What is the ChartMill fundamental rating of CXAPP INC (CXAI) stock?

ChartMill assigns a fundamental rating of 2 / 10 to CXAI.


What is the valuation status for CXAI stock?

ChartMill assigns a valuation rating of 0 / 10 to CXAPP INC (CXAI). This can be considered as Overvalued.


What is the profitability of CXAI stock?

CXAPP INC (CXAI) has a profitability rating of 1 / 10.


What is the financial health of CXAPP INC (CXAI) stock?

The financial health rating of CXAPP INC (CXAI) is 3 / 10.


Can you provide the expected EPS growth for CXAI stock?

The Earnings per Share (EPS) of CXAPP INC (CXAI) is expected to decline by -20.69% in the next year.